▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / AURX

AURX — Nuo Therapeutics, Inc.

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 1091596 ·
Last close
$0.99
Market Cap
$47.92M
52W High
$1.70
52W Low
$0.94
ADV30
3,703
Next earnings
—
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,302,115 849,727 -446,466 -618,466 1,945,669 263,827 3,329,532
Dec 2025 1,096,830 688,369 -579,338 -578,480 1,845,662 548,946 2,802,221
Jun 2025 700,202 540,852 -652,022 -649,689 1,359,485 316,354 2,184,047
Mar 2025 484,381 363,360 -745,147 -746,128 1,146,754 55,655 1,359,827

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-648,994
Investing CF
$-274,756
Financing CF
$1,439,542
CapEx
$-425,618
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-34,772,162
Inventory
$213,761
Receivables
$561,667
ST Investments
—
EBIT TTM
$-2,605,741
Pretax Income TTM
$-2,470,963
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,313,509 -2,516,649 -2,512,216 1,845,662 2,802,221 — -864,971
Dec 2024 1,365,173 -2,457,835 -2,323,705 1,189,508 675,796 — -2,231,622
Dec 2023 608,525 -3,168,274 -3,171,436 1,877,880 838,732 — -3,167,782
Dec 2022 112,250 -3,320,594 -3,171,736 3,047,360 856,022 — -3,706,126

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.01

Peers — same industry

TickerNameMarket CapLastDaily %
BDMD Baird Medical Investment Holdings Ltd $48.59M $1.58 —
BEAT HeartBeam, Inc. $49.57M $0.89 —
IDXG INTERPACE BIOSCIENCES, INC. $49.86M $1.80 —
PSTV PLUS THERAPEUTICS, INC. $45.43M $6.60 —
ARAY ACCURAY INC $44.56M $0.37 —

News headlines (Yahoo Finance, 1h cache)

Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 21:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →